Paying users zone. Data is covered by hidden.

  • Get to Bristol-Myers Squibb Co. for $15.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc


Short-term (Operating) Activity Analysis

Difficulty: Beginner


Ratios (Summary)

Bristol-Myers Squibb Co., short-term (operating) activity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Turnover Ratios
Inventory turnover hidden hidden hidden hidden hidden
Receivables turnover hidden hidden hidden hidden hidden
Payables turnover hidden hidden hidden hidden hidden
Working capital turnover hidden hidden hidden hidden hidden
Average No. of Days
Average inventory processing period hidden hidden hidden hidden hidden
Add: Average receivable collection period hidden hidden hidden hidden hidden
Operating cycle hidden hidden hidden hidden hidden
Less: Average payables payment period hidden hidden hidden hidden hidden
Cash conversion cycle hidden hidden hidden hidden hidden

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

Ratio Description The company
Inventory turnover An activity ratio calculated as cost of goods sold divided by inventory. Bristol-Myers Squibb Co.'s inventory turnover improved from 2015 to 2016 and from 2016 to 2017.
Receivables turnover An activity ratio equal to revenue divided by receivables. Bristol-Myers Squibb Co.'s receivables turnover deteriorated from 2015 to 2016 and from 2016 to 2017.
Payables turnover An activity ratio calculated as cost of goods sold divided by payables. Bristol-Myers Squibb Co.'s payables turnover increased from 2015 to 2016 but then slightly declined from 2016 to 2017 not reaching 2015 level.
Working capital turnover An activity ratio calculated as revenue divided by working capital. Bristol-Myers Squibb Co.'s working capital turnover deteriorated from 2015 to 2016 and from 2016 to 2017.
Average inventory processing period An activity ratio equal to the number of days in the period divided by inventory turnover over the period. Bristol-Myers Squibb Co.'s average inventory processing period improved from 2015 to 2016 and from 2016 to 2017.
Average receivable collection period An activity ratio equal to the number of days in the period divided by receivables turnover. Bristol-Myers Squibb Co.'s average receivable collection period deteriorated from 2015 to 2016 and from 2016 to 2017.
Operating cycle Equal to average inventory processing period plus average receivables collection period. Bristol-Myers Squibb Co.'s operating cycle improved from 2015 to 2016 and from 2016 to 2017.
Average payables payment period An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period. Bristol-Myers Squibb Co.'s average payables payment period declined from 2015 to 2016 but then increased from 2016 to 2017 not reaching 2015 level.
Cash conversion cycle A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period. Bristol-Myers Squibb Co.'s cash conversion cycle deteriorated from 2015 to 2016 but then improved from 2016 to 2017 exceeding 2015 level.

Inventory Turnover

Bristol-Myers Squibb Co., inventory turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Cost of products sold hidden hidden hidden hidden hidden
Inventories hidden hidden hidden hidden hidden
Ratio
Inventory turnover1 hidden hidden hidden hidden hidden
Benchmarks
Inventory Turnover, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Inventory Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Inventory Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Inventory turnover = Cost of products sold ÷ Inventories
= hidden ÷ hidden = hidden

Ratio Description The company
Inventory turnover An activity ratio calculated as cost of goods sold divided by inventory. Bristol-Myers Squibb Co.'s inventory turnover improved from 2015 to 2016 and from 2016 to 2017.

Receivables Turnover

Bristol-Myers Squibb Co., receivables turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net product sales hidden hidden hidden hidden hidden
Net trade receivables hidden hidden hidden hidden hidden
Ratio
Receivables turnover1 hidden hidden hidden hidden hidden
Benchmarks
Receivables Turnover, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Receivables Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Receivables Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Receivables turnover = Net product sales ÷ Net trade receivables
= hidden ÷ hidden = hidden

Ratio Description The company
Receivables turnover An activity ratio equal to revenue divided by receivables. Bristol-Myers Squibb Co.'s receivables turnover deteriorated from 2015 to 2016 and from 2016 to 2017.

Payables Turnover

Bristol-Myers Squibb Co., payables turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Cost of products sold hidden hidden hidden hidden hidden
Accounts payable hidden hidden hidden hidden hidden
Ratio
Payables turnover1 hidden hidden hidden hidden hidden
Benchmarks
Payables Turnover, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Payables Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Payables Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Payables turnover = Cost of products sold ÷ Accounts payable
= hidden ÷ hidden = hidden

Ratio Description The company
Payables turnover An activity ratio calculated as cost of goods sold divided by payables. Bristol-Myers Squibb Co.'s payables turnover increased from 2015 to 2016 but then slightly declined from 2016 to 2017 not reaching 2015 level.

Working Capital Turnover

Bristol-Myers Squibb Co., working capital turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Current assets hidden hidden hidden hidden hidden
Less: Current liabilities hidden hidden hidden hidden hidden
Working capital hidden hidden hidden hidden hidden
Net product sales hidden hidden hidden hidden hidden
Ratio
Working capital turnover1 hidden hidden hidden hidden hidden
Benchmarks
Working Capital Turnover, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Working Capital Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Working Capital Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Working capital turnover = Net product sales ÷ Working capital
= hidden ÷ hidden = hidden

Ratio Description The company
Working capital turnover An activity ratio calculated as revenue divided by working capital. Bristol-Myers Squibb Co.'s working capital turnover deteriorated from 2015 to 2016 and from 2016 to 2017.

Average Inventory Processing Period

Bristol-Myers Squibb Co., average inventory processing period calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data
Inventory turnover hidden hidden hidden hidden hidden
Ratio (no. of days)
Average inventory processing period1 hidden hidden hidden hidden hidden
Benchmarks (no. of days)
Average Inventory Processing Period, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Average Inventory Processing Period, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Average Inventory Processing Period, Industry
Health Care hidden hidden hidden hidden hidden

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ hidden = hidden

Ratio Description The company
Average inventory processing period An activity ratio equal to the number of days in the period divided by inventory turnover over the period. Bristol-Myers Squibb Co.'s average inventory processing period improved from 2015 to 2016 and from 2016 to 2017.

Average Receivable Collection Period

Bristol-Myers Squibb Co., average receivable collection period calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data
Receivables turnover hidden hidden hidden hidden hidden
Ratio (no. of days)
Average receivable collection period1 hidden hidden hidden hidden hidden
Benchmarks (no. of days)
Average Receivable Collection Period, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Average Receivable Collection Period, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Average Receivable Collection Period, Industry
Health Care hidden hidden hidden hidden hidden

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ hidden = hidden

Ratio Description The company
Average receivable collection period An activity ratio equal to the number of days in the period divided by receivables turnover. Bristol-Myers Squibb Co.'s average receivable collection period deteriorated from 2015 to 2016 and from 2016 to 2017.

Operating Cycle

Bristol-Myers Squibb Co., operating cycle calculation, comparison to benchmarks

No. of days

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data
Average inventory processing period hidden hidden hidden hidden hidden
Average receivable collection period hidden hidden hidden hidden hidden
Ratio
Operating cycle1 hidden hidden hidden hidden hidden
Benchmarks
Operating Cycle, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Operating Cycle, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Operating Cycle, Industry
Health Care hidden hidden hidden hidden hidden

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Operating cycle = Average inventory processing period + Average receivable collection period
= hidden + hidden = hidden

Ratio Description The company
Operating cycle Equal to average inventory processing period plus average receivables collection period. Bristol-Myers Squibb Co.'s operating cycle improved from 2015 to 2016 and from 2016 to 2017.

Average Payables Payment Period

Bristol-Myers Squibb Co., average payables payment period calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data
Payables turnover hidden hidden hidden hidden hidden
Ratio (no. of days)
Average payables payment period1 hidden hidden hidden hidden hidden
Benchmarks (no. of days)
Average Payables Payment Period, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Average Payables Payment Period, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Average Payables Payment Period, Industry
Health Care hidden hidden hidden hidden hidden

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ hidden = hidden

Ratio Description The company
Average payables payment period An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period. Bristol-Myers Squibb Co.'s average payables payment period declined from 2015 to 2016 but then increased from 2016 to 2017 not reaching 2015 level.

Cash Conversion Cycle

Bristol-Myers Squibb Co., cash conversion cycle calculation, comparison to benchmarks

No. of days

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data
Average inventory processing period hidden hidden hidden hidden hidden
Average receivable collection period hidden hidden hidden hidden hidden
Average payables payment period hidden hidden hidden hidden hidden
Ratio
Cash conversion cycle1 hidden hidden hidden hidden hidden
Benchmarks
Cash Conversion Cycle, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Cash Conversion Cycle, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Cash Conversion Cycle, Industry
Health Care hidden hidden hidden hidden hidden

Source: Based on data from Bristol-Myers Squibb Co. Annual Reports

2017 Calculations

1 Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= hidden + hiddenhidden = hidden

Ratio Description The company
Cash conversion cycle A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period. Bristol-Myers Squibb Co.'s cash conversion cycle deteriorated from 2015 to 2016 but then improved from 2016 to 2017 exceeding 2015 level.